12:00 AM
 | 
Nov 15, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

VEGF165 gene medicine: Phase II

An interim analysis of 27 patients showed an increase in the number of blood vessels in patients receiving VEGF via intravascular administration of VLTS's plasmid or an...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >